LATEST
Peeking into the Future of Synthetic Biology and Gene Editing, an Exclusive Interview with Dr. George Church
2020-02-13
Yet Another Feather in Merck’s Crown, Keytruda Meets Endpoint in Phase 3 Trial for Triple Negative Breast Cancer
2020-02-13
Rare Disease Biotech, Azafaros Finds Big Money in Small Molecules, Raises US$ 28M in Series A
2020-02-12